Results 1 to 10 of about 57,565 (259)

Mesothelioma

open access: yesCytojournal, 2022
Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial cavities. It has three variants including: epithelioid, sarcomatous/desmoplastic, and biphasic types.
Rao, Nagarjun, Wei, Shuanzeng
core   +5 more sources

Diagnosis and management of pleural mesothelioma: three unique cases and review of the literature [PDF]

open access: yesBMC Pulmonary Medicine
Background Mesothelioma is a rare pleural tumor. Compared to diffuse pleural mesothelioma, localized pleural mesothelioma carries a better prognosis and may be managed with surgical resection.
Zeina Al Achkar   +2 more
doaj   +2 more sources

Mesothelioma [PDF]

open access: yesJournal of Thoracic Oncology, 2012
Malignant pleural mesothelioma (MPM) is a rare cancer mostly associated with asbestos exposure (reviewed in1) although very recently it has been found that germline mutations in BRCA1 associated protein-1 (BAP1) may predispose to mesothelioma development
Emanuela Felley-Bosco   +3 more
core   +3 more sources

Malignant mesothelioma [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2008
Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium and the tunica vaginalis.
Parker Robert J   +2 more
core   +4 more sources

Mesothelioma [PDF]

open access: yesCancers, 2021
Malignant mesothelioma is a disease affecting serosal surfaces derived from the mesothelium comprising the pleura, peritoneum, pericardium, and tunica vaginalis testis [...]
openaire   +2 more sources

Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire

open access: yesBMJ Open Respiratory Research, 2022
Objectives Malignant mesothelioma is an aggressive malignancy of mesothelial surfaces, most commonly those of the pleura. The aim of this study was to understand, using a national questionnaire, the gendered care experiences of patients with malignant ...
Liz Darlison   +4 more
doaj   +1 more source

Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial

open access: yesEClinicalMedicine, 2022
Summary: Background: Currently, there is no US Food and Drug Administration approved therapy for patients with pleural mesothelioma who have relapsed following platinum-doublet based chemotherapy. Vinorelbine has demonstrated useful clinical activity in
Dean A. Fennell   +16 more
doaj   +1 more source

The therapeutic implications of the genomic analysis of malignant pleural mesothelioma

open access: yesNature Communications, 2021
Delineation of the genomic complexities of malignant pleural mesothelioma (MPM) has lagged behind other malignancies. Zhang et al. meaningfully add to our understanding of MPM, and their findings emphasize the need to combine drug development efforts ...
Marjorie G. Zauderer
doaj   +1 more source

Must countries shoulder the burden of mesothelioma to ban asbestos? A global assessment

open access: yesBMJ Global Health, 2022
Introduction Mesothelioma is a key asbestos-related disease (ARD) but can be difficult to diagnose. Countries presumably ban asbestos to reduce future ARD burdens, but it is unknown if countries ban asbestos as a consequence of ARD burdens.
Seong-Kyu Kang   +10 more
doaj   +1 more source

Malignant Peritoneal Mesothelioma Diagnosed by a Laparoscopy : A Case Report [PDF]

open access: yes, 2023
Malignant mesothelioma is rare, and its prognosis is markedly poor. It is often difficult to distinguish malignant mesothelioma from carcinomatous peritonitis of other solid tumors.
品川, 真奈花   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy